Amerise Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	0.22	0.21	0.14	0.13	0.19
Cash & Short-Term Investments	0.24	0.22	0.21	0.14	0.13	0.19
Cash Growth	49.06%	5.21%	55.15%	4.61%	-32.69%	-23.13%
Accounts Receivable	-	-	-	-	62.17	-
Receivables	-	-	-	-	62.17	-
Other Current Assets	-	0.05	0.02	-	-0	-
Total Current Assets	-	0.27	0.23	0.14	62.29	0.19
Long-Term Investments	-	23.81	22.65	45.66	46.91	30.41
Other Long-Term Assets	-	-	-	-	-0	-
Total Assets	-	84.63	53.9	56.47	119.88	56.28
Accounts Payable	-	-	-	-	62.66	4.8
Current Income Taxes Payable	-	0.02	-	-	-	-
Other Current Liabilities	-	30.82	0.16	0.37	0.01	0.57
Total Current Liabilities	-	30.84	0.16	0.37	62.67	5.38
Long-Term Debt	-	-	-	0.9	0.83	-
Other Long-Term Liabilities	-	-	-	-	-0	-
Total Liabilities	-	30.84	0.16	1.27	63.49	5.38
Common Stock	-	66.07	66.07	66.07	66.07	66.07
Retained Earnings	-	-13.09	-13.14	-11.68	-10.49	-15.98
Comprehensive Income & Other	-	0.81	0.81	0.81	0.81	0.81
Shareholders' Equity	53.29	53.8	53.74	55.2	56.39	50.9
Total Liabilities & Equity	-	84.63	53.9	56.47	119.88	56.28
Total Debt	-	-	-	0.9	0.83	-
Net Cash (Debt)	0.24	0.22	0.21	-0.76	-0.7	0.19
Net Cash Growth	49.06%	5.21%	-	-	-	-23.13%
Net Cash Per Share	0.01	0.00	0.00	-0.01	-0.01	0.00
Filing Date Shares Outstanding	21.3	66.07	66.07	66.07	66.07	66.07
Total Common Shares Outstanding	21.3	66.07	66.07	66.07	66.07	66.07
Working Capital	-	-30.57	0.07	-0.23	-0.37	-5.19
Book Value Per Share	1.26	0.81	0.81	0.84	0.85	0.77
Tangible Book Value	53.29	53.8	53.74	55.2	56.39	50.9
Tangible Book Value Per Share	1.26	0.81	0.81	0.84	0.85	0.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.